Yüklüyor......

Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development

Poly (ADP-ribose) polymerase (PARP) inhibitors have shown promising activity in epithelial ovarian cancers, especially relapsed platinum-sensitive high-grade serous disease. Consistent with preclinical studies, ovarian cancers and a number of other solid tumor types occurring in patients with delete...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Scott, Clare L., Swisher, Elizabeth M., Kaufmann, Scott H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4517072/
https://ncbi.nlm.nih.gov/pubmed/25779564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.58.8848
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!